REPARE THERAPEUTICS
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. The company's drugs combine a proprietary high throughput gene-editing and target discovery method with high-resolution protein crystallography, computational biology and clinical informatics, enabling patients to improve cancer treatment both with single therapy and in combination with existing drugs and treatments.
REPARE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Saint Laurent, Quebec, Canada
Country:
Canada
Website Url:
http://www.reparerx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
251.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Font Awesome Amazon IPv6 ReCAPTCHA Cloudflare
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series B - Repare Therapeutics
Redmile Group
Redmile Group investment in Series B - Repare Therapeutics
Business Development Bank of Canada
Business Development Bank of Canada investment in Series B - Repare Therapeutics
OrbiMed
OrbiMed investment in Series B - Repare Therapeutics
Versant Ventures
Versant Ventures investment in Series B - Repare Therapeutics
UBS Oncology Impact Fund
UBS Oncology Impact Fund investment in Series B - Repare Therapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Repare Therapeutics
BVF Partners
BVF Partners investment in Series B - Repare Therapeutics
Amplitude Venture Capital
Amplitude Venture Capital investment in Series B - Repare Therapeutics
Logos Capital
Logos Capital investment in Series B - Repare Therapeutics
Key Employee Changes
Official Site Inspections
http://www.reparerx.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K
- Host name: 172.67.132.139
- IP address: 172.67.132.139
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Repare Therapeutics"
Repare Therapeutics | Synthetic Lethality Precision Oncology
We are leveraging our proprietary SNIPRx ® platform to discover, validate and build a robust pipeline of synthetic lethality-based therapeutics. We are developing a portfolio of product …See details»
Repare Therapeutics | Synthetic Lethality | Job Openings
Join our team and help us accomplish our mission of bringing novel therapies to people with cancer. Repare is dedicated to creating an environment where all can feel comfortable being their true selves, where people are able to share their …See details»
Repare Therapeutics - LinkedIn
We use our genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA …See details»
Repare | Synthetic Lethality Precision Oncology | Leadership
We have assembled a highly qualified management team with broad and deep oncology and biotech experience to execute on our mission to develop novel precision oncology therapies …See details»
Repare Therapeutics | Precision Oncology | Repare Therapeutics ...
Nov 12, 2024 · For more information, please visit reparerx.com and follow @Reparerx on X (formerly Twitter) and LinkedIn. Forward-Looking Statements. This press release contains …See details»
Repare Therapeutics - Crunchbase Company Profile
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. The company's drugs combine a proprietary high throughput gene-editing and target discovery method with high-resolution …See details»
Repare Therapeutics Doses First Patient in Camonsertib …
Jun 10, 2024 · CAMBRIDGE, Mass. & MONTREAL-- ( BUSINESS WIRE )--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology …See details»
Repare Therapeutics - MassBio
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.See details»
Precision Oncology | Investor Relations - Repare Therapeutics
Oct 13, 2023 · Corporate Profile for Repare Therapeutics, a clinical-stage precision oncology company discovering and developing novel, synthetic lethal medicines.See details»
Repare Therapeutics Provides Corporate Update and Highlights ...
Jan 8, 2024 · CAMBRIDGE, Mass. & MONTREAL -- (BUSINESS WIRE)--Jan. 8, 2024-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage …See details»
Repare | Synthetic Lethal Therapies | Discovery Platform
Learn about scientifc discovery platorm at Repare Therapeutics, a clinical-stage precision oncology company developing novel, synthetic lethal medicines.See details»
Repare Therapeutics - Overview, News & Similar companies
Feb 29, 2024 · View Repare Therapeutics (www.reparerx.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Repare Therapeutics - LinkedIn
We use our genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA …See details»
Repare Therapeutics Provides Corporate Update and Highlights …
Jan 7, 2022 · Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of …See details»
Repare Therapeutics | Precision Oncology | Repare Therapeutics …
Mar 31, 2022 · Repare’s platform enables the development of precision therapeutics in patients whose tumors contain one or more genomic alterations identified by SNIPRx® screening, in …See details»
Repare Therapeutics Information - RocketReach
Repare Therapeutics is a Biotechnology Research, Pharmaceuticals, and Healthcare company located in Montreal, Quebec with $7.8 million in revenue and 184 employees. Find top …See details»
Repare Therapeutics (RPTX) | Portfolio | Versant Ventures
Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA …See details»
Repare Therapeutics | Precision Oncology | Investor Relations
(µ/ý Xda j»©QD IDâ ¡! ˆ € €ìÀ ⣠ZY$ ² 5B)bÙ‹ ±EZï ¡- P ò÷üÿ„ Ùš‘ÝäQ‹]ok€ × Ý ž ï°£7Ĺ£L¹iù+xjûÝÒ÷ -žZþ 1 ...See details»
reparerx.org
Reparerx.orgSee details»
Repare Therapeutics | Precision Oncology | Repare Therapeutics …
Is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.See details»